Coats Group (COA) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
17 Jul, 2025Business highlights
Achieved 2% CER revenue growth, with strong performance in Apparel & Footwear and increased market share despite market uncertainty.
Group adjusted EBIT margin rose to 19.8%, within the 19-21% medium-term target range.
Completed exit from North American Yarns business, focusing on higher-margin segments.
Revenue from 100% recycled thread products surged 73% to $269m, reinforcing sustainability leadership.
Organic adjacency sales grew 30% year-on-year, supporting revenue acceleration.
OrthoLite acquisition
Entered a definitive agreement to acquire OrthoLite Holdings LLC for $770m enterprise value.
OrthoLite is a global leader in open-cell foam insole technology, with c.36% market share and 550 brand partners.
Acquisition creates a 'Super Tier 2' supplier, combining leadership in threads and insoles for critical footwear components.
OrthoLite brings 14 global production facilities and a complementary footprint to existing operations.
Transaction funded by 20% equity placing and debt, with net leverage expected below 2x by end of 2026.
Strategic rationale and synergy
Combination enhances scale, innovation, and sustainability, with strong alignment on growth enablers.
Identified $20m in joint cost synergies by FY28, with additional revenue synergy potential.
Proforma footwear revenue expected to reach c.$700m, with margin accretion and EPS accretive from first full year.
Enhanced customer intimacy and cross-selling opportunities with global brands.
Strong track record of M&A integration and margin enhancement from previous acquisitions.
Latest events from Coats Group
- Record cash flow, margin gains, and upgraded targets highlight robust 2025 performance.COA
H2 20255 Mar 2026 - Record 18% EBIT margin, strong growth, and upgraded outlook led by Apparel and Footwear.COA
H1 20242 Feb 2026 - UK pension liabilities fully hedged, unlocking $30m cash for growth and shareholder returns.COA
Investor Update22 Jan 2026 - Strong revenue and margin growth, robust cash flow, and de-risked pension position support future expansion.COA
H2 20246 Jan 2026 - $770M OrthoLite deal creates a footwear leader, targeting $20M synergies by 2028.COA
M&A Announcement16 Dec 2025 - Revenue down 1% with stable profit; OrthoLite acquisition and divisional restructure completed.COA
Q3 2025 TU7 Nov 2025 - OrthoLite acquisition and record margins drive growth, cash flow, and future synergies.COA
H1 202517 Jul 2025 - Double-digit sales growth and robust margins position Coats for continued momentum.COA
Trading Update13 Jun 2025 - Revenue up 4% with margin gains; US Yarns exit to boost profitability and portfolio quality.COA
Trading Update6 Jun 2025